China approves clinical trials of third Covid-19 vaccine candidate

27th April 2020 (Last Updated April 27th, 2020 07:26)

China has granted approval to assess a third coronavirus vaccine candidate against Covid-19 in the second phase of clinical trials.

According to state-run Xinhua news agency, an inactivated vaccine created by Wuhan Institute of Biological Products under the China National Pharmaceutical Group, Sinopharm, and the Wuhan Institute of Virology (WIV) entered clinical trials.

Read the full article here